You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
藥明巨諾-B(02126.HK):超額配股權獲部分行使 涉及1172.95萬股
格隆匯 11-29 20:06

格隆匯 11 月 29日丨藥明巨諾-B(02126.HK)公佈,聯席全球協調人(代表國際包銷商)已於2020年11月27日部分行使招股章程所述的超額配股權,涉及合共1172.95萬股股份,相當於根據全球發售初步可供認購的發售股份總數(行使任何超額配股權前)約12.01%。公司將按每股股份23.80港元(不包括1%經紀佣金、0.0027%證監會交易徵費及0.005%聯交所交易費)配發及發行超額配發股份。超額配發股份將用於向WuXi AppTec (Hong Kong) Holding Limited歸還為補足國際發售中股份超額分配而借入的部分股份。

公司進一步宣佈,全球發售的穩定價格期已於2020年11月27日(即遞交香港公開發售申請的截止日期起計第30日)結束。有關穩定價格經辦人於穩定價格期進行的穩定價格行動。

聯交所上市委員會已批准超額配發股份上市及買賣。預期超額配發股份將於2020年12月2日上午九時正於聯交所主板開始上市及買賣。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account